Physician profile
David A Sutter
NPI 1457512063
$2,166.32
in general payments reported to CMS, 2019-2025
22 companies · $473 in 2025
The $473 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2021: $55.33 · 2022: $73.10 · 2023: $119 · 2024: $797 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127 · Travel and Lodging: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.21 |
| Travel and Lodging | $261.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $616.02 | 2019-2025 | Watchman Flx, Farapulse, Watchman |
| Edwards Lifesciences Corporation | $426.45 | 2024 | Pascal |
| Abbott Laboratories | $267.08 | 2019-2022 | |
| Abiomed | $222.72 | 2019-2025 | Impella |
| Novo Nordisk INC | $94.55 | 2024-2025 | Ozempic, Wegovy |
| Novartis Pharmaceuticals Corporation | $81.70 | 2019-2025 | |
| Cardiovascular Systems INC. | $75.12 | 2019-2022 | |
| Teleflex LLC | $70.16 | 2022-2024 | Guideliner |
| Amgen INC. | $61.72 | 2022-2024 | Repatha |
| Atricure, INC. | $44.83 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.99 | 2024-2025 | Lifevest |
| Cordis US Corp. | $39.23 | 2025 | Mynx Control Venous |
| Biotronik INC. | $25.42 | 2025 | Acticor 7 Vr-T Dx |
| Biosense Webster, INC. | $24.44 | 2025 | Nuvision Ice Catheter |
| Janssen Pharmaceuticals, INC | $21.25 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $18.75 | 2019 | |
| Terumo Medical Corporation | $18.50 | 2019 | |
| Pfizer INC. | $16.39 | 2023 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.